Abeona Therapeutics
ABEO
ABEO
87 hedge funds and large institutions have $230M invested in Abeona Therapeutics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 23 increasing their positions, 31 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
12% less funds holding
Funds holding: 99 → 87 (-12)
26% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 31
75% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 16
Holders
87
Holding in Top 10
1
Calls
$2.29M
Puts
$732K
Top Buyers
| 1 | +$3.04M | |
| 2 | +$1.94M | |
| 3 | +$1.07M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$810K |
| 5 |
BlackRock
New York
|
+$737K |
Top Sellers
| 1 | -$6M | |
| 2 | -$2.1M | |
| 3 | -$1.93M | |
| 4 |
Citigroup
New York
|
-$1.3M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.03M |